CH719763A2 - Composition for skin or nail application - Google Patents
Composition for skin or nail application Download PDFInfo
- Publication number
- CH719763A2 CH719763A2 CH000697/2022A CH6972022A CH719763A2 CH 719763 A2 CH719763 A2 CH 719763A2 CH 000697/2022 A CH000697/2022 A CH 000697/2022A CH 6972022 A CH6972022 A CH 6972022A CH 719763 A2 CH719763 A2 CH 719763A2
- Authority
- CH
- Switzerland
- Prior art keywords
- composition
- macerate
- oily
- composition according
- skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
On décrit une composition pour application cutanée ou unguéale, à visée réparatrice, dont le but est de protéger et soulager la zone lésée du pied ou de la main du patient par une combinaison d'action mécanique, anti-inflammatoire, analgésique et antifongique, permettant ainsi de réduire le temps de traitement et soulager plus rapidement le patient. Une telle composition peut prendre en poids: de 70.0 à 95.0% de paraffine liquide, de 15.0 à 20.0 % de polymère, de 0,5 à 3,0 % d'Huile essentielle de Tea Tree, de 0,5 à 3,0 % de macérât huileux d'Arnica, de 0,5 à 3.0 % de macérât huileux d'Aloe Vera ainsi que l'addition de 2 à 10 % dans la composition finale d'un mélange d'huiles végétales. D'autres actifs pourront complémenter la composition, tels que des oligo-éléments ou encore des vitamines liposolubles. Cette composition peut être moulée afin de constituer une orthèse ou imprégnée directement sur une orthèse en tissu, afin de favoriser une application optimale et précise, en quantité (g/cm2 de peau ou d'ongle) du produit. En effet, afin d'obtenir le meilleur résultat cutané ou unguéale, il est indispensable que le produit soit appliqué à raison de 0,40 mg/cm2 à 2,90mg/cm2 de peau.A composition for cutaneous or nail application, with a restorative aim, is described, the aim of which is to protect and relieve the injured area of the patient's foot or hand by a combination of mechanical, anti-inflammatory, analgesic and antifungal action, allowing thus reducing treatment time and providing faster relief to the patient. Such a composition can take by weight: from 70.0 to 95.0% liquid paraffin, from 15.0 to 20.0% polymer, from 0.5 to 3.0% Tea Tree essential oil, from 0.5 to 3.0 % of oily Arnica macerate, 0.5 to 3.0% of oily Aloe Vera macerate as well as the addition of 2 to 10% in the final composition of a mixture of vegetable oils. Other active ingredients may complement the composition, such as trace elements or fat-soluble vitamins. This composition can be molded to form an orthosis or impregnated directly onto a fabric orthosis, in order to promote optimal and precise application, in quantity (g/cm2 of skin or nail) of the product. Indeed, in order to obtain the best skin or nail result, it is essential that the product is applied at a rate of 0.40 mg/cm2 to 2.90 mg/cm2 of skin.
Description
[0001] Composition pour application cutanée ou unguéale, à visée réparatrice, dont le but est de protéger et soulager le pied ou la main du patient par une combinaison d'action mécanique, anti-inflammatoire, analgésique et antifongique, permettant ainsi de réduire le temps de traitement et soulager plus rapidement le patient. [0001] Composition for cutaneous or nail application, with a restorative aim, the aim of which is to protect and relieve the patient's foot or hand by a combination of mechanical, anti-inflammatory, analgesic and antifungal action, thus making it possible to reduce the treatment time and relieve the patient more quickly.
[0002] Cette composition permet de remédier aux principaux inconvénients présentés par les traitements actuels connus en podologie ou traitement de la main, à savoir une efficacité limitée du fait de l'absence de prise en charge des frottements et micro-chocs combinés avec les risques inflammatoires et fongiques au niveau de la zone lésée. En effet, lors d'une lésion du pied ou de la main, le soulagement sera plus rapide sur une zone isolée mécaniquement et traitée dans le même temps par une action anti-inflammatoire, analgésique et anti-fongique. La présente invention se présente sous forme d'orthèse moulée directement ou par imprégnation d'une orthèse en tissus, afin de favoriser une application précise, en quantité du produit/cm2 de peau. [0002] This composition makes it possible to remedy the main disadvantages presented by current treatments known in podiatry or hand treatment, namely limited effectiveness due to the absence of treatment for friction and micro-shocks combined with the risks inflammatory and fungal infections in the injured area. Indeed, during an injury to the foot or hand, relief will be more rapid in a mechanically isolated area and treated at the same time with an anti-inflammatory, analgesic and antifungal action. The present invention is presented in the form of an orthosis molded directly or by impregnation of a fabric orthosis, in order to promote precise application, in quantity of the product/cm2 of skin.
[0003] A cet effet, la composition suivant l'invention comprend au moins, de la paraffine liquide, un polymère, de l'huile essentielle de Tea Tree, du macérât huileux d'Arnica, du macérât huileux d'Aloe Vera ainsi que l'addition dans la composition finale d'un mélange d'huiles végétales. [0003] For this purpose, the composition according to the invention comprises at least liquid paraffin, a polymer, Tea Tree essential oil, Arnica oily macerate, Aloe Vera oily macerate as well as the addition in the final composition of a mixture of vegetable oils.
[0004] Suivant une forme de réalisation de l'invention, la paraffine liquide est une paraffine liquide de qualité pharmaceutique [0004] According to one embodiment of the invention, the liquid paraffin is a liquid paraffin of pharmaceutical quality
[0005] Suivant une forme de réalisation de l'invention, le polymère est un co-polymère tribloc. [0005] According to one embodiment of the invention, the polymer is a triblock co-polymer.
[0006] Suivant une forme de réalisation avantageuse, l'huile essentielle de Tea Tree est obtenue par distillation complète par entraînement à la vapeur d'eau [0006] According to an advantageous embodiment, the Tea Tree essential oil is obtained by complete distillation by distillation with steam.
[0007] Suivant une forme de réalisation de l'invention, le macérât huileux d'Arnica est obtenue par macération solaire de fleurs d'Arnica biologique dans de l'huile de Tournesol biologique [0007] According to one embodiment of the invention, the oily Arnica macerate is obtained by solar maceration of organic Arnica flowers in organic Sunflower oil
[0008] Suivant une forme de réalisation de l'invention, le macérât huileux d'Aloe Vera est obtenue par macération de jus d'Aloe Vera biologique dans de l'huile de Tournesol biologique [0008] According to one embodiment of the invention, the oily Aloe Vera macerate is obtained by maceration of organic Aloe Vera juice in organic Sunflower oil.
[0009] Suivant un avantage de l'invention, la composition comprend, en poids : de 70.0 à 95.0% de paraffine liquide, de 15.0 à 20.0 % de polymère, de 0,5 à 3,0 % d'Huile essentielle de Tea Tree, de 0,5 à 3,0 % de macérât huileux d'Arnica, de 0,5 à 3.0 % de macérât huileux d'Aloe Vera ainsi que l'addition de 2 à 10 % dans la composition finale d'un mélange d'huiles végétales. [0009] According to an advantage of the invention, the composition comprises, by weight: from 70.0 to 95.0% of liquid paraffin, from 15.0 to 20.0% of polymer, from 0.5 to 3.0% of Tea essential oil Tree, from 0.5 to 3.0% of Arnica oily macerate, from 0.5 to 3.0% of Aloe Vera oily macerate as well as the addition of 2 to 10% in the final composition of a mixture vegetable oils.
[0010] D'autres détails et particularités de l'invention ressortiront de la description ci-après, à titre d'exemples non-limitatifs, de compositions destinées à améliorer l'état cutanée ou unguéale, du pied ou de la main du patient. [0010] Other details and particularities of the invention will emerge from the description below, by way of non-limiting examples, of compositions intended to improve the skin or nail condition of the patient's foot or hand.
[0011] La composition susdite peut également contenir de la Vitamine E améliorant son efficacité, introduit dans la composition à raison de 0.001% à 0.01% en poids. [0011] The above-mentioned composition may also contain Vitamin E improving its effectiveness, introduced into the composition at a rate of 0.001% to 0.01% by weight.
[0012] La composition susdite peut également contenir en plus de 0.01% à 0.10% en poids de vitamine A ou D. [0012] The above-mentioned composition may also contain from 0.01% to 0.10% by weight of vitamin A or D.
[0013] On a obtenu d'excellents résultats sur l'amélioration de l'état inflammatoire et un soulagement rapide de la zone lésée, en particulier des résultats durables, avec une composition comprenant en poids: 80.0% de paraffine liquide, 15 % de co-polymère tribloc, 1 % d'Huile essentielle de Tea Tree, de 1 % de macérât huileux d'Arnica, 1 % de macérât huileux d'Aloe Vera ainsi que l'addition de 2% dans la composition finale d'un mélange d'huiles végétales riches en vitamines liposolubles. [0013] Excellent results were obtained on the improvement of the inflammatory state and rapid relief of the injured area, in particular lasting results, with a composition comprising by weight: 80.0% of liquid paraffin, 15% of triblock co-polymer, 1% Tea Tree essential oil, 1% Arnica oily macerate, 1% Aloe Vera oily macerate as well as the addition of 2% in the final composition of a mixture vegetable oils rich in fat-soluble vitamins.
[0014] Cette composition peut être moulée afin de constituer une orthèse ou imprégnée directement sur une orthèse en tissu. [0014] This composition can be molded to form an orthosis or impregnated directly onto a fabric orthosis.
[0015] Afin d'obtenir le meilleur résultat cutané, il est indispensable que le produit soit appliqué à raison de 0,40 mg/cm2 à 2,90mg/cm2 de peau [0015] In order to obtain the best skin result, it is essential that the product be applied at a rate of 0.40 mg/cm2 to 2.90 mg/cm2 of skin
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH000697/2022A CH719763A2 (en) | 2022-06-08 | 2022-06-08 | Composition for skin or nail application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH000697/2022A CH719763A2 (en) | 2022-06-08 | 2022-06-08 | Composition for skin or nail application |
Publications (1)
Publication Number | Publication Date |
---|---|
CH719763A2 true CH719763A2 (en) | 2023-12-15 |
Family
ID=89158748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH000697/2022A CH719763A2 (en) | 2022-06-08 | 2022-06-08 | Composition for skin or nail application |
Country Status (1)
Country | Link |
---|---|
CH (1) | CH719763A2 (en) |
-
2022
- 2022-06-08 CH CH000697/2022A patent/CH719763A2/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0278809B1 (en) | Cosmetic or dermatologic compositions containing a silybum marianum fruit extract rich in sylimarin together with essential fatty acids | |
FR2487356A1 (en) | STABLE EMULSIONS OBTAINED FROM A NATURAL EMULSIFYING AGENT STABILIZED BY ALOE SUCK | |
WO1999039695A1 (en) | Emulsion for transdermal administration of an active principle | |
EP1885374A2 (en) | Pharmaceutical composition comprising an oleaginous ointment and vitamin d or the derivatives thereof in solubilised form | |
EP3878431A1 (en) | Deodorant cosmetic composition comprising zinc ricinoleate | |
KR20150013162A (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
FR2539992A1 (en) | OIL-IN-WATER TYPE CREAM COMPRISING HYDROCORTISONE BUTYRO-PROPIONATE, PREPARATION METHOD AND THERAPEUTIC APPLICATION | |
WO2018172379A1 (en) | Use of a copaifera extract to combat alopecia and seborrhea | |
FR2490492A1 (en) | Compsns. for treating cellulitis - contg. xanthine base and seaweed extract | |
EP1758588B1 (en) | Pharmaceutical composition comprising an ointment and two solubilized active principles | |
CH719763A2 (en) | Composition for skin or nail application | |
CA2416934A1 (en) | Fungicidal composition comprising in particular an oil of vegetable origin with high drying power | |
FR2700956A1 (en) | Cosmetic and pharmaceutical composition and process for its preparation | |
EP0679087B1 (en) | Cosmetic or pharmaceutical and particularly dermatological composition containing a vismia extract | |
FR2609630A1 (en) | New cosmetic or dermatological compositions containing an extract of Silybum marianum fruits which is rich in silymarin combined with essential fatty acids | |
EP4093370A1 (en) | Composition comprising hyaluronic acid and a polyol and/or carboxymethyl cellulose | |
FR2949059A1 (en) | PROCESS FOR THE PREPARATION OF AN INTEGRAL JUICE OF OLIVE, COMPOSITION OBTAINED ACCORDING TO SAID METHOD AND ITS APPLICATION IN THE FIELD OF COSMETICS AND DIETETICS | |
FR2742055A1 (en) | Liquid plant extract mixture | |
EP3600242B1 (en) | Hydrocarbon oil for a therapeutic use | |
FR2543828A1 (en) | NOVEL ANTI-ACNEIC COMPOSITION BASED ON TIOXOLONE AND AT LEAST ONE OTHER ACTIVE INGREDIENT | |
CH670951A5 (en) | Cosmetic, cicatrising and disinfectant emulsions - contain vitamin=A ester and hydrogen peroxide | |
CA3056293A1 (en) | Use of copaifera oleoresin in pathologies of the prostate | |
CH717634A2 (en) | Composition for topical application, for moisturizing the skin of diabetics, with the aim of promoting a reduction in the loss of hydration and skin aging, resulting from the phenomenon of glycation. | |
WO2020083694A1 (en) | Dermatological composition intended for the prevention and/or treatment of mastodynia | |
FR2518404A1 (en) | ANALGESIC COMPOSITION COMPRISING AT LEAST ONE ACUTE NEUTRALIZED ALCOHOLIC PHTHALATE BASED ON PEAT EXTRACTS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AZW | Rejection (application) |